Gemma Sánchez Espín

Dr. Gemma Sánchez Espín

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
FCFernando Carrasco-Chinchilla
Fernando Carrasco-Chinchilla
GEGemma Sánchez Espín
Gemma Sánchez Espín
JRJosefa Ruiz-Morales
Josefa Ruiz-Morales
IRIsabel Rodríguez–Bailón
Isabel Rodríguez–Bailón
JMJose M. Melero–Tejedor
Jose M. Melero–Tejedor
ETEduardo de Teresa–Galván
Eduardo de Teresa–Galván

19 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CRCarmen Rueda-Martínez
Carmen Rueda-Martínez
OLOscar Lamas
Oscar Lamas
MMMaría José Mataró
María José Mataró
JRJuan Robledo-Carmona
Juan Robledo-Carmona
GEGemma Sánchez Espín
Gemma Sánchez Espín
BFBorja Fernández
Borja Fernández
Dilatation of the ascending aorta (AAD) is a prevalent aortopathy that occurs frequently associated with bicuspid aortic valve (BAV), the most common human congenital cardiac malformation. The molecular mechanisms leading to AAD associated with BAV are still poorly understood. The search for differentially expressed genes in diseased tissue by quantitative real-time PCR (qPCR) is an invaluable tool to fill this gap. However, studies dedicated to identify reference genes necessary for normalization of mRNA expression in aortic tissue are scarce. In this report, we evaluate the qPCR expression of six candidate reference genes in tissue from the ascending aorta of 52 patients with a variety of clinical and demographic characteristics, normal and dilated aortas, and different morphologies of the aortic valve (normal aorta and normal valve n = 30; dilated aorta and normal valve n = 10; normal aorta and BAV n = 4; dilated aorta and BAV n = 8). The expression stability of the candidate reference genes was determined with three statistical algorithms, GeNorm, NormFinder and Bestkeeper. The expression analyses showed that the most stable genes for the three algorithms employed were CDKN1β, POLR2A and CASC3, independently of the structure of the aorta and the valve morphology. In conclusion, we propose the use of these three genes as reference genes for mRNA expression analysis in human ascending aorta. However, we suggest searching for specific reference genes when conducting qPCR experiments with new cohort of samples.

15 September 2016 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
CRCarmen Rueda-Martínez
Carmen Rueda-Martínez
OLOscar Lamas
Oscar Lamas
MMMaría José Mataró
María José Mataró
JRJuan Robledo-Carmona
Juan Robledo-Carmona
GEGemma Sánchez Espín
Gemma Sánchez Espín
BFBorja Fernández
Borja Fernández
OBJECTIVES: Bicuspid aortic valve (BAV) is the most prevalent congenital cardiac malformation, frequently associated with aortic dilatation (AD). The molecular mechanisms involved in AD and its aetiological link with BAV formation are poorly understood. Altered fibrillin-1 (FBN1) and metalloprotease-2, -9 (MMP2,9) protein activities have been suggested to be involved in BAV aortopathy. In addition, FBN2 participates in embryonic valve formation, but its possible involvement in BAV-associated AD has never been explored. In this report, we evaluate the expression levels of MMP2,9 and FBN1,2 in the ascending aorta of patients with normal or dilated aortas and with tricuspid aortic valve (TAV) or BAV, using appropriate tissue-specific reference genes. METHODS: Gene expression was quantified by real-time quantitative polymerase chain reaction in 52 patients, using one or three reference genes previously validated in the same patient population. RESULTS:FBN2 expression was significantly increased in the aortas of patients with BAV compared with individuals with TAV (0.178 ± 0.042 vs 0.096 ± 0.021, P = 0.015), whereas differences in FBN1 did not reach statistical significance (1.946 ± 0.228 vs 1.430 ± 0.114, P = 0.090). When four groups of samples were considered, FBN2 expression was significantly higher in patients with BAV and AD compared with patients with TAV and AD (0.164 ± 0.035 vs 0.074 ± 0.027, P = 0.040). No significant differences were found when FBN1/FBN2 ratio, and MMP2 and MMP9 expression levels were analysed. No linear relationship between aortic diameter and gene expression levels were found. CONCLUSIONS: BAV patients have an increased FBN (especially FBN2) gene expression level in the ascending aorta, irrespective of dilatation, whereas MMP expression does not change significantly. These results add a new piece of information to the pathophysiology of BAV disease and point to FBN2 as a new molecular player.

1 September 2001 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
VRV Riambau
V Riambau
RLR.J.F Laheij
R.J.F Laheij
CGC Garcı́a-Madrid
C Garcı́a-Madrid
GEGemma Sánchez Espín
Gemma Sánchez Espín

1 January 2009 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
JCJuan Caballero-Borrego
Juan Caballero-Borrego
JDJuan Jose Gomez Doblas
Juan Jose Gomez Doblas
FVFélix M. Valencia-Serrano
Félix M. Valencia-Serrano
FCFernando Cabrera-Bueno
Fernando Cabrera-Bueno
IRIsabel Rodríguez-Bailón
Isabel Rodríguez-Bailón
ETEduardo de Teresa-Galván
Eduardo de Teresa-Galván

1 January 2017 in International Journal of Medical Sciences
Verified
Journal Article
Open access
LPLuis Miguel Pérez-Belmonte
Luis Miguel Pérez-Belmonte
IMInmaculada Moreno-Santos
Inmaculada Moreno-Santos
FCFernando Cabrera-Bueno
Fernando Cabrera-Bueno
GEGemma Sánchez Espín
Gemma Sánchez Espín
DCDaniel Castellano-Castillo
Daniel Castellano-Castillo
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
Objectives: Sterol regulatory element-binding proteins (SREBP) genes are crucial in lipid biosynthesis and cardiovascular homeostasis. Their expression in epicardial adipose tissue (EAT) and their influence in the development of coronary artery disease (CAD) and type-2 diabetes mellitus remain to be determined. The aim of our study was to evaluate the expression of SREBP genes in EAT in patients with CAD according to diabetes status and its association with clinical and biochemical data.